A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
|Slideshows|February 24, 2022
COVID-19 vs Influenza: 7 Questions on What Makes Them Different
Author(s)Sydney Jennings
Advertisement
COVID-19 and influenza are similar and different in various ways, and differentating between the two is critical as the pandemic's second year is underway. Patient Care Online previously
Advertisement
Related to this article
FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
Lumateperone reduced acute mania symptoms by day 3 in a phase 3 bipolar 1 trial, according to Johnson & Johnson.
Endocrine Society statement highlights key research gaps on obesity drugs—who benefits, long-term dosing, safety, and measuring success beyond weight loss.
Finerenone wins FDA clearance for type 1 diabetes–related CKD, lowering albuminuria in FINE-ONE and opening a long-awaited treatment path.
New American Society of Hematology guidelines raise ferritin cutoffs to catch iron deficiency sooner, including pregnancy and inflammation, and add TSAT for clearer diagnosis.
The US FDA cleared a novel insulin patch pump that can be used for up to 3 days with an additional 12-hour grace period in persons with diabetes.
Advertisement
Advertisement
Trending on Patient Care Online
1
Endocrine Society Obesity Statement Calls for Goals Beyond Weight Loss
2
Lumateperone Reduces Acute Mania Symptoms in Phase 3 Bipolar I Trial
3
Combating Prostate Cancer Misconceptions in Primary Care: An Expert Discussion
4
Unmet Needs and Mechanisms Behind Newer Agitation Therapies
5